FDA Proposes Amendments to DTC Regulations

The FDA has proposed amendments to its regulations on direct-to-consumer prescription drug advertising.  Mass Tort Defense reports that:

The new proposal would require disclosure of the major side effects and contraindications of the drug in a clear, conspicuous, and neutral manner, regardless of the manner in which effectiveness information is presented in the advertisement. 

Full story at Mass Tort Defense.

– SBS